SCIENTIFIC AGENDA

Presidential Symposium
Chairs: Rafael Rosell, MD and Frances A. Shepherd, MD
Discussants: Chandra P. Belani, MD, Peter Goldstraw, MB, FRCS, Valerie W. Rusch, MD and Richard Stephens, PhD

ANITA: Phase III Adjuvant Vinorelbine (N) and Cisplatin (P) versus observation in completely resected (Stage I-III) Non small Cell Lung Cancer (NSCLC) patients (pts): On behalf of Adjuvant Navelbine International Trial Association.
Rafael Rosell, MD

Percutaneous radiofrequency ablation of primary NSCLC
Marcello Carlo Ambrogi, MD, PhD

President's Session
Discussant: Peter Goldtraw, MB, FRCS

Prospective study of accuracy of redo videomediastinoscopy and PET-CT in detecting residual mediastinal disease after induction chemotherapy for NSCLC
Discussant: Prof. Dr. Paul De Leyn

Prospective study of accuracy of redo videomediastinoscopy and PET-CT in detecting residual mediastinal disease after induction therapy
Discussant: Valerie Rusch, MD

Longitudinal evaluation of quality of life in long-term lung cancer survivors
Ping Yang, MD, PhD

Discussant: Richard Stephens, PhD